Blog
RSS FeedPosted by Michael Wonder on 24 Jul 2017
Merck announces U.S. launch of Renflexis (infliximab-abda), a biosimilar of remicade, for all eligible indications
24 July 2017 - Merck today announced the U.S. launch of Renflexis (infliximab-abda), a biosimilar of the originator biologic medicine ...
Posted by Michael Wonder on 03 Sep 2015
Novartis launches first U.S. 'biosimilar' drug at 15 percent discount
3 September 2015 - Novartis kicked off a new era in U.S. medicine on Thursday with the launch of the first ...
Posted by Michael Wonder on 03 Sep 2015
Sandoz launches Zarxio (filgrastim-sndz), the first biosimilar in the United States
3 September 2015 - Sandoz, a Novartis company, announced today that Zarxio (filgrastim-sndz) is now available in the United States. Zarxio ...